STOCK TITAN

Camden National Corporation Form 4 Filings

CAC NASDAQ

Every Form 4 that Camden National Corporation (CAC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CAC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CAC filings page.

Rhea-AI Summary

CAMDEN NATIONAL CORP (CAC) reported that director Raina Maxwell received a grant of 249 shares of common stock on September 18, 2026 as a stock award in lieu of director fees under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment. The filing also notes an additional 28.935 shares accumulated since the prior report through participation in the company's dividend reinvestment program, bringing Maxwell's directly held common stock to a total of 4,310.753 shares after these acquisitions. No transactions are reported under a Rule 10b5-1 trading plan.

Rhea-AI Summary

CAMDEN NATIONAL CORP (CAC) director Rebecca Hatfield reported an acquisition of company stock through compensation-related awards. On September 18, 2026, she received 152 shares of Common Stock at $57.55 per share as a grant under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees. A footnote also states that her holdings include 0.352 additional shares acquired since the last filing through participation in the company's dividend reinvestment program, bringing her direct ownership to 8,783.797 shares after the reported transactions. No transactions were reported under a Rule 10b5-1 trading plan.

Rhea-AI Summary

CAMDEN NATIONAL CORP (CAC) director Carl John Soderberg reported receiving a grant of 275 shares of Common Stock on September 18, 2026. The shares were acquired at a reported value of $57.55 per share under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees. Following this award, he directly holds 104,624.218 shares of Camden National common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Summary

CAMDEN NATIONAL CORP (symbol: CAC) is the issuer of record for a Form 4 filing submitted to the SEC. Haynes Larry K reported acquisition or exercise transactions in this Form 4 filing.

CAMDEN NATIONAL CORP (CAC) reported that director Larry K. Haynes received a grant of 249 shares of Common Stock on September 18, 2026 at a value of $57.55 per share. The shares were awarded under Camden National Corporation's 2022 Equity and Incentive Plan in lieu of director fees, and no Rule 10b5-1 trading plan is reported. After this award, he held 1,447 shares directly and 3,217.888 shares indirectly through a revocable trust.

Rhea-AI Summary

CAMDEN NATIONAL CORP (symbol: CAC) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

CAMDEN NATIONAL CORP (CAC) reported that EVP Joshua M. Nash acquired equity-based awards in the form of common stock on August 14, 2026. He received 632 and 834 shares of restricted stock awards and 246 restricted stock units under the company’s 2022 Equity and Incentive Plan and Amendment. These awards vest pro-rata over their respective service periods, subject to continued employment, with each award or unit converting into one share of common stock at vesting. Following these grants, Nash’s equity includes 5,191 restricted stock units and restricted shares subject to vesting and forfeiture restrictions, and there is also an indirect holding of 1,682.799 shares of common stock held by his spouse.

Rhea-AI Summary

Brunelle Katherine W reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp EVP Katherine W. Brunelle received three equity grants totaling 1,855 shares of common stock on July 15, 2026. The awards comprise restricted stock and restricted stock units under the 2022 Equity and Incentive Plan, vesting pro-rata over service periods. Following these grants, she holds 2,184 restricted stock units and restricted shares subject to vesting and forfeiture restrictions.

Rhea-AI Summary

CAMDEN NATIONAL CORP executive David Ackley (EVP) reported a routine tax-withholding transaction related to equity compensation. On July 15, 2026, 34 shares of common stock were withheld at $54.16 per share to satisfy minimum tax obligations on restricted stock units that vested that day. Following this withholding, Ackley directly holds 13,359.958 shares of common stock, including 5,291 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp director Raina Maxwell reported an equity grant of common stock. Maxwell acquired 279 shares of Camden National Corp common stock on June 18, 2026 at a reference value of $51.49 per share. The shares were issued under Camden National Corporation's 2022 Equity and Incentive Plan in lieu of director fees, meaning this was a compensation-related award rather than an open-market purchase. Following this grant, Maxwell directly holds 4,032.818 shares of Camden National Corp common stock.

Rhea-AI Summary

Camden National Corp director Rebecca Hatfield received 170 shares of Common Stock as an equity grant. The shares were valued at $51.49 each and were issued under Camden National Corporation's 2022 Equity and Incentive Plan as compensation in lieu of director fees.

After this award, Hatfield directly holds a total of 8,631.445 Camden National shares. This transaction is a routine, non-market acquisition of stock as part of the company’s standard director compensation program rather than an open-market purchase.

Rhea-AI Summary

Camden National Corp director Carl John Soderberg received an equity award of 308 shares of common stock on June 18, 2026. The shares were acquired under Camden National Corporation's 2022 Equity and Incentive Plan in lieu of director fees, at a reference price of $51.49 per share. Following this compensation-related grant, Soderberg directly holds 104,349.218 Camden National common shares.

Rhea-AI Summary

Camden National Corp director Larry K. Haynes received a stock grant as part of his board compensation. On 2026-06-18, he acquired 279 shares of common stock at $51.49 per share under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

Following this grant, Haynes directly holds 1,198 common shares and indirectly holds 3,217.888 common shares through a revocable trust. This reflects a routine, compensation-related equity award rather than an open-market purchase or sale.

Rhea-AI Summary

Soderberg Carl John reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director Carl John Soderberg received a grant of 919 shares of Common Stock as equity compensation. The award was made under the Independent Directors' Equity Compensation Program, which is part of the 2022 Equity and Incentive Plan and its amendment.

The shares were granted at no cash cost and vested immediately on the grant date. Following this award, Soderberg directly holds a total of 104,041.218 shares of Camden National Corp common stock.

Rhea-AI Summary

McCarthy Marie J reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director Marie J. McCarthy received a grant of 919 shares of Common Stock on June 1, 2026 as equity compensation. The award was made under the Independent Directors' Equity Compensation Program, part of the 2022 Equity and Incentive Plan and its amendment, at no cash cost to her.

The shares vested immediately on the grant date. After this grant and prior dividend reinvestments, McCarthy directly holds a total of 16,941.818 Camden National Corp shares, including 275.647 shares accumulated through the company’s dividend reinvestment program since her last filing.

Rhea-AI Summary

SAWYER ROBIN A reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director Robin A. Sawyer received a stock grant of 919 shares of Common Stock. The shares were awarded at no cost under the Independent Directors' Equity Compensation Program, part of the 2022 Equity and Incentive Plan and Amendment, and vested immediately on the grant date.

Following this award, Sawyer directly holds a total of 11,390.697 Camden National shares. This filing reflects routine equity-based compensation for an independent director rather than an open-market purchase or sale.

Rhea-AI Summary

Camden National Corp director Raina Maxwell received a stock grant as part of board compensation. On the grant date, Maxwell acquired 919 shares of Common Stock under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment. The shares vested immediately and carried no purchase price to the director, reflecting a compensation award rather than a market purchase.

After this grant and additional dividend reinvestments, Maxwell now directly holds 3,753.818 shares, including 24.132 shares accumulated since the last filing through the company's dividend reinvestment program.

Rhea-AI Summary

CAMDEN NATIONAL CORP director Larry K. Haynes reported routine equity and ownership updates. On June 1, 2026, he acquired 919 shares of Common Stock at no cost as a stock grant under the Independent Directors' Equity Compensation Program, which vested immediately.

On May 11, 2026, 3,217.888 shares of Common Stock were moved from his direct holdings into a revocable trust, where he serves as trustee and retains voting and dispositive power, so there was no change in his beneficial ownership. Footnotes also note 33.057 additional shares accumulated since the last filing through the company’s dividend reinvestment program.

Rhea-AI Summary

Merrill Robert D reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director Robert D. Merrill received a stock grant of 919 shares of Common Stock as compensation. The shares were granted under the Independent Directors' Equity Compensation Program, which is part of the 2022 Equity and Incentive Plan and its amendment.

The grant carried no purchase price and vested immediately on the grant date, meaning Merrill gained full ownership right away. Following this award, his direct holdings increased to 11,423.8065 shares of Camden National Corp common stock, reflecting a routine, compensation-related equity increase rather than an open-market purchase.

Rhea-AI Summary

Longley S. Catherine reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director Catherine S. Longley received an equity award of 919 shares of Common Stock under the company’s Independent Directors' Equity Compensation Program, part of the 2022 Equity and Incentive Plan and Amendment. The grant carried no purchase price and vested immediately on the grant date.

Following this award, Longley directly holds a total of 14,512.613 shares of Camden National Corp common stock. This filing reflects routine director compensation rather than an open-market stock purchase or sale.

Rhea-AI Summary

Page James H reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director James H. Page received a grant of 919 shares of Common Stock as equity compensation. The shares were awarded under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment, and vested immediately on the grant date. After this award, Page directly holds 10,896 shares of Camden National Corp common stock.

Rhea-AI Summary

Denekas Craig N reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director Craig N. Denekas received a grant of 919 shares of common stock. The shares were awarded on June 1, 2026 under the Independent Directors' Equity Compensation Program, which is part of the 2022 Equity and Incentive Plan and Amendment.

The award was an equity compensation grant with no cash price per share and vested immediately on the grant date. Following this grant, Denekas directly holds 15,999 shares of Camden National common stock, reflecting his updated ownership position as a director.

Rhea-AI Summary

Hatfield Rebecca reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director Rebecca Hatfield received a grant of 919 shares of common stock under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment. The award carried no purchase price and vested immediately on the grant date.

Following this compensation grant, Hatfield directly holds a total of 8,461.445 shares of Camden National common stock. A footnote also notes an additional 0.422 share accumulated since the prior filing through participation in the company’s dividend reinvestment program.

Rhea-AI Summary

Camden National Corp EVP Garrett McKnight had 45 shares of Common Stock withheld on May 15, 2026 to cover minimum tax obligations on restricted stock units that vested that day. The shares were valued at $47.34 per share and this was not an open-market sale.

After this tax-withholding disposition, McKnight directly holds 6,223 shares of Camden National stock, including 4,248 restricted stock units and restricted shares that remain subject to future vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp executive Michael R. Archer had shares withheld to cover taxes on vesting stock awards. On April 29 and 30, 2026, a total of 337 common shares were withheld to satisfy minimum tax withholding obligations on restricted shares that vested on those dates.

After these tax-withholding dispositions, he directly holds 21,089.44 common shares, including 8,579 restricted stock units and restricted shares subject to vesting and forfeiture, plus 87.367 shares acquired through the company’s dividend reinvestment program.

Rhea-AI Summary

Camden National Corp EVP Renee Smyth reported routine share dispositions related to tax withholding on vested equity awards. On April 29, 2026, 140 shares of common stock were withheld at $47.97 per share, followed by 118 shares on April 30, 2026 at $48.17 per share. These transactions were classified as tax-withholding dispositions, not open-market sales. After the April 30 transaction, Smyth directly held 29,280.604 shares of common stock. Footnotes state that holdings include 5,967 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp executive Ryan A. Smith reported routine tax-related share withholdings tied to vesting equity awards. On April 29 and April 30, 2026, a total of 296 shares of common stock were withheld at prices of $47.97 and $48.17 per share to cover minimum tax withholding obligations on restricted shares that vested on those dates.

After these tax-withholding dispositions, Smith directly holds 23,980 shares of Camden National common stock. His holdings also include 6,709 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions, reflecting ongoing equity-based compensation rather than open-market trading activity.

Rhea-AI Summary

Camden National Corp executive Barbara Raths reported routine tax-withholding share dispositions tied to restricted stock vesting. On April 29, 2026, 131 shares of common stock were withheld at $47.97 per share, and on April 30, 2026, 104 shares were withheld at $48.17 per share to cover minimum tax obligations on vested restricted shares. After these non‑market transactions, she directly owned 9,106 common shares, and her holdings also include 5,252 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp CEO Simon Griffiths reported routine tax-related share withholdings tied to restricted stock vesting. On April 29, 2026, 824 shares of common stock were withheld at $47.97 per share, leaving him with 43,575 directly held shares. On April 30, 2026, a further 776 shares were withheld at $48.17 per share, after which he directly held 42,799 shares. Footnotes explain these were the minimum shares withheld to satisfy tax obligations on restricted shares that vested on those dates, and that his holdings include 25,650 restricted stock units and restricted shares subject to vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp executive Andrew Forbes reported routine share withholdings to cover taxes on vesting stock awards. On April 29 and April 30, 2026, a total of 224 shares of common stock were withheld as minimum tax payments on restricted shares that vested on those dates. These Form 4 entries are coded as tax-withholding dispositions, not open-market sales. After these transactions, Forbes holds 5,923 shares of common stock directly, along with 4,054 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp EVP Patricia A. Rose reported routine share withholdings for taxes tied to restricted stock vesting. On April 29, 158 shares of common stock were withheld at $47.97 per share, and on April 30, 134 shares were withheld at $48.17 per share.

These Form 4 entries reflect tax-withholding dispositions rather than open-market sales. After these transactions, Rose directly held about 28,777.352 shares of Camden National common stock, including 4,109 restricted stock units and restricted shares subject to vesting and forfeiture terms.

Rhea-AI Summary

Camden National Corp EVP David Ackley reported routine tax-related share withholdings. On April 29 and 30, 2026, a total of 241 shares of common stock were withheld at prices of $47.97 and $48.17 per share to satisfy minimum tax obligations on vested restricted shares.

After these tax-withholding dispositions, Ackley directly holds 13,393.958 common shares, which include 5,402 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions. These transactions do not represent open-market purchases or sales but standard tax-settlement mechanics tied to equity compensation.

Rhea-AI Summary

CAMDEN NATIONAL CORP executive William H. Martel reported routine share withholdings for taxes related to equity awards. On April 29 and April 30, 2026, a total of 294 shares of common stock were withheld at prices of $47.97 and $48.17 per share to satisfy minimum tax withholding obligations on restricted shares that vested on those dates. These are not open-market sales but tax-withholding dispositions connected to vesting. Following these transactions, Martel directly holds 21,904 shares of common stock, which includes 7,384 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp EVP Garrett McKnight reported routine tax-related share withholdings tied to vesting equity awards. On April 29 and April 30, 2026, a total of 241 shares of common stock were withheld to satisfy minimum tax obligations on restricted shares that vested on those dates.

After these transactions, McKnight directly held 6,268 shares of common stock. This holding includes 4,398 restricted stock units and restricted shares that remain subject to vesting and forfeiture restrictions. The Form 4 indicates tax-withholding dispositions rather than open-market sales.

Rhea-AI Summary

Smith Ryan A reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp EVP Ryan A. Smith received an equity grant of 1,281 shares of Common Stock. The award was made as restricted stock under the company’s 2022 Equity and Incentive Plan and amendment at a value of $50.67 per share.

The restricted stock awards are scheduled to vest pro-rata over the next three years, contingent on his continued employment through each vesting date. Each restricted stock award represents the right to receive one share of common stock upon vesting. Following this grant, Smith directly holds 24,276 shares of Camden National common stock, which include 7,711 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp CEO Simon Griffiths received an equity grant of 6,919 shares of Common Stock, awarded as restricted stock under the company’s 2022 Equity and Incentive Plan and its amendment. The award is priced at $50.67 per share for reporting purposes.

The restricted stock is scheduled to vest pro rata over the next three years, subject to Griffiths’ continued employment through each vesting date. Each restricted stock award converts into one share of common stock at vesting. After this grant, he directly holds 44,399 shares, including 31,098 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp EVP William H. Martel received an award of 1,281 shares of common stock, granted as restricted stock under the company’s 2022 Equity and Incentive Plan and its amendment. The award is scheduled to vest pro-rata over the next three years, conditioned on continued employment through each vesting date.

Each restricted stock award converts into one share of common stock upon vesting. After this grant, Martel directly holds 22,198 shares of Camden National common stock, including 8,380 restricted stock units and restricted shares that remain subject to vesting and forfeiture provisions.

Rhea-AI Summary

Forbes Andrew reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp executive Andrew Forbes received a compensation-related equity grant rather than buying shares on the market. On this Form 4, the EVP was granted 1,036 shares of common stock as restricted stock awards at a reference price of $50.67 per share.

The awards were granted under the company’s 2022 Equity and Incentive Plan and are scheduled to vest pro-rata over the next three years, subject to continued employment through each vesting date. After this grant, Forbes directly holds 6,147 common shares, including 4,815 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Rose Patricia A reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp EVP Patricia A. Rose received a grant of 1,281 shares of common stock valued at $50.67 per share. The award is in the form of restricted stock under the company’s 2022 Equity and Incentive Plan and its amendment.

The restricted shares are scheduled to vest pro-rata over the next three years, conditioned on continued employment through each vesting date. After this grant, Rose directly holds a total of 28,923.593 common shares, including 5,098 restricted stock units and restricted shares that remain subject to vesting and forfeiture terms.

Rhea-AI Summary

Camden National Corp EVP David Ackley received a grant of 1,087 shares of common stock as a restricted stock award. The grant was made at $50.67 per share under the company’s 2022 Equity and Incentive Plan and is scheduled to vest pro-rata over the next three years, subject to continued employment.

Each restricted stock award converts into one share of common stock at vesting. After this award, Ackley directly holds 13,634.958 shares of common stock, which include 6,222 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Archer Michael R reported acquisition or exercise transactions in this Form 4 filing.

CAMDEN NATIONAL CORP EVP Michael R. Archer received an equity grant of 1,922 shares of common stock as a restricted stock award. The grant value is based on a price of $50.67 per share and is part of the company’s 2022 Equity and Incentive Plan and its amendment.

The restricted shares are scheduled to vest pro rata over the next three years, conditioned on his continued employment through each vesting date. After this grant, Archer directly holds a total of 21,339.073 shares of common stock, including 9,725 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Smyth Renee reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp executive Renee Smyth received a routine equity grant in company stock. She was awarded 1,174 shares of common stock on April 28, 2026 at a grant value of $50.67 per share under the 2022 Equity and Incentive Plan and its amendment.

The award consists of restricted stock scheduled to vest pro-rata over the next three years, subject to continued employment. After this grant, Smyth directly holds 29,538.604 shares of common stock, which includes 6,844 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp EVP Barbara Raths received an equity grant of 1,105 shares of common stock, reported as a restricted stock award under the company’s 2022 Equity and Incentive Plan and its amendment. The award is compensation, not an open-market purchase, and is scheduled to vest pro-rata over the next three years, subject to her continued employment through each vesting date.

Each restricted stock award converts into one share of common stock at vesting. Following this grant, she directly holds a total of 9,341 shares of Camden National common stock, including 6,051 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp executive vice president Garrett McKnight received a grant of 1,139 shares of common stock as restricted stock awards at a reference value of $50.67 per share. These awards are scheduled to vest pro-rata over three years, contingent on continued employment.

Following the grant, McKnight directly holds 6,509 shares of common stock, including 5,214 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions. Each restricted stock award converts into one share of common stock upon vesting.

Rhea-AI Summary

Camden National Corp EVP David Ackley reported routine tax-related share withholdings tied to vesting equity awards. On April 24, 2026, a total of 299 shares of common stock were withheld at $49.68 per share to satisfy minimum tax obligations.

Footnotes explain that 213 shares related to restricted shares and 86 shares related to restricted stock units from the 2023–2025 Long-Term Performance Plan that vested on April 25, 2026. These are not open-market sales; they are automatic tax-withholding dispositions, and Ackley continues to hold more than 12,000 shares directly.

Rhea-AI Summary

Camden National Corp CEO Simon Griffiths reported routine tax-withholding transactions related to equity awards. On restricted shares and restricted stock units that vested on April 25, 2026, a total of 1,896 common shares were withheld to cover minimum tax obligations, using the April 24, 2026 price of $49.68 per share. After these dispositions, Griffiths directly holds 38,834 common shares, including 24,179 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions. These Form 4 entries reflect compensation-related tax withholding rather than open-market buying or selling.

Rhea-AI Summary

CAMDEN NATIONAL CORP EVP Michael R. Archer reported routine tax-withholding share dispositions related to equity awards. On April 24, 2026, a total of 398 shares of Common Stock were withheld at $49.68 per share to satisfy minimum tax withholding obligations on restricted shares and restricted stock units that vested on April 25, 2026 under the issuer's 2023-2025 Long-Term Performance Plan. These F-code transactions are not open-market sales but shares delivered back to the issuer for taxes. After these dispositions, Archer directly holds 19,417.073 shares of Common Stock, including 7,803 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp EVP Renee Smyth reported routine share withholdings tied to equity awards. On April 24, 2026, a total of 369 shares of common stock were disposed of at $49.68 per share to satisfy minimum tax withholding on restricted shares and restricted stock units that vested on April 25, 2026. After these tax-withholding dispositions, Smyth directly owns about 28,364.604 shares of common stock, including 5,670 restricted stock units and restricted shares subject to vesting and forfeiture conditions.

Rhea-AI Summary

CAMDEN NATIONAL CORP executive Barbara Raths reported share dispositions tied to tax withholding, not market trades. On April 24, 2026, a total of 260 shares of common stock were withheld at $49.68 per share to cover minimum tax obligations on equity awards that vested on April 25, 2026.

Footnotes explain that 162 shares were withheld for restricted shares that vested, and 98 shares were withheld for restricted stock units granted under the issuer's 2023-2025 Long-Term Performance Plan. These transactions are coded as tax-withholding dispositions and reflect compensation-related withholding rather than open-market buying or selling.

Rhea-AI Summary

CAMDEN NATIONAL CORP EVP Patricia A. Rose reported routine share withholdings to cover taxes on equity awards that vested. On April 24, 2026, a total of 424 shares of common stock were disposed of through tax-withholding transactions tied to restricted shares and restricted stock units.

The footnotes explain that 303 shares were withheld for minimum tax obligations on vested restricted shares and 121 shares were withheld for taxes on restricted stock units granted under the 2023-2025 Long-Term Performance Plan. Rose continues to hold directly owned shares along with 3,817 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.

Rhea-AI Summary

Camden National Corp EVP William H. Martel reported tax-related share dispositions rather than open-market trades. A total of 438 shares of common stock were withheld at $49.68 per share on April 24, 2026 to cover minimum tax withholding obligations tied to equity awards.

The footnotes state that part of the shares came from restricted shares that vested on April 25, 2026, and part from restricted stock units granted under the issuer's 2023-2025 Long-Term Performance Plan that also vested on that date. The filing also notes 7,099 restricted stock units and restricted shares remain subject to vesting and forfeiture conditions.